American Century NT Intl Gr Instl (ACLNX - MF report) a Zacks Ranked #2 (Buy) seeks capital growth. ACLNX invests primarily in securities of companies located in at least three developed countries world-wide, excluding the United States. Under normal market conditions, ACLNX’s portfolio will primarily consist of securities of companies whose earnings or revenues are not only growing, but growing at an accelerating pace. It is not permitted to invest in securities issued by companies assigned the Global Industry Classification Standard for the tobacco industry.
This Non US – Equity fund, as of the last filing, allocates their fund in three major groups; Foreign Stock, High Yield Bond, Intermediate Bond. As of the last filing, Novartis AG (NVS), Roche Holding AG (RHHBY) Genuss (GENSF) and Nestle SA (NSRGF) were the top holdings for ACLNX.
The American Century NT Intl Gr Instl fund, managed by American Cent , carries an expense ratio of 0.98.
ACLNX has a history of strong positive total returns for over 10 years. Specifically, the fund’s returns over the 1, 3, 5 year benchmarks; 1 year 2.42%, 3 year 15.83%, and 5 year 11.34%. To see how this fund performed compared in its category, please click here.
ACLNX’s performance, as of the last filing, when compared to funds in its category was in the top 26% in 1 year, top 20% over the past 3 years, and in the 17% over the past 5 years.
